Institutional & Family Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Institutional & Family Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8	Closed	-$1K	–	1022
2021 Q1	$1K	Sell	8 -4	-33%	-$792	﹤0.01%	910
2020 Q4	$3K	Hold	12	–	–	﹤0.01%	735
2020 Q3	$2K	Buy	12 +3	+33%	+$411	﹤0.01%	745
2020 Q2	$1K	Sell	9 -2	-18%	-$194	﹤0.01%	819
2020 Q1	$1K	Hold	11	–	–	﹤0.01%	789
2019 Q4	$1K	Buy	+11	New	+$1.06K	﹤0.01%	836

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Institutional & Family Asset Management's MRTX Position: Q2 2021 in Review

Institutional & Family Asset Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2021, closing a stake of 8 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in MRTX in Q4 2019 and held it in 6 quarters. The position peaked at $3K in Q4 2020. 245 funds tracked by Wall St. Rank hold MRTX as of Q2 2021.

Institutional & Family Asset Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Institutional & Family Asset Management sold 8 Mirati Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $1K.
Institutional & Family Asset Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
Institutional & Family Asset Management's Mirati Therapeutics, Inc. Common Stock position peaked at $3K in Q4 2020.
245 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Institutional & Family Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.